Cargando…
Methylation of CpG Sites as Biomarkers Predictive of Drug-Specific Patient Survival in Cancer
BACKGROUND: Though the development of targeted cancer drugs continues to accelerate, doctors still lack reliable methods for predicting patient response to standard-of-care therapies for most cancers. DNA methylation has been implicated in tumor drug response and is a promising source of predictive...
Autores principales: | Neary, Bridget, Lin, Shuting, Qiu, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634212/ https://www.ncbi.nlm.nih.gov/pubmed/36340286 http://dx.doi.org/10.1177/11769351221131124 |
Ejemplares similares
-
Evaluation of single CpG sites as proxies of CpG island methylation states at the genome scale
por: Barrera, Víctor, et al.
Publicado: (2012) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016) -
CpG Methylation in Aging: Trajectories of Individual Sites
por: Meer, Margarita, et al.
Publicado: (2020) -
CpG Site-Based Signature Predicts Survival of Colorectal Cancer
por: Wu, Jiande, et al.
Publicado: (2022) -
Cytosine methylation at CpCpG sites triggers accumulation of non-CpG methylation in gene bodies
por: Zabet, Nicolae Radu, et al.
Publicado: (2017)